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Abstract
Objective: The SLC26A4 protein (pendrin) seems to be involved in the exchange of chloride with other
anions, therefore being responsible for iodide organification in the thyroid gland and the conditioning
of the endolymphatic fluid in the inner ear. Malfunction of SLC26A4 leads to Pendred syndrome,
characterized by mild thyroid dysfunction often associated with goiter and/or prelingual deafness.
The precise function of the SLC26A4 protein, however, is still elusive. An open question is still
whether the SLC26A4-induced ion exchange mechanism is electrogenic or electroneutral. Recently,
it has been shown that human pendrin expressed in monkey cells leads to chloride currents.
Methods: We overexpressed the human SLC26A4 isoform in HEK293 Phoenix cells and measured
cationic and anionic currents by the patch-clamp technique in whole cell configuration.
Results: Here we show that human pendrin expressed in human cells does not lead to the activation of
chloride currents, but, in contrast, leads to an increase of cationic currents.
Conclusion: Our experiments suggest that the SLC26A4-induced chloride transport is electroneutral
when expressed in human cellular systems.
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Introduction
The SLC26 proteins belong to a family of anion
transporters. The characteristics of these transporters
vary depending on the subtype of the transporters
and/or the tissue in which the transporters are
expressed, i.e. the SLC26A4 transporter exchanges
chloride by another anion which can be as different
as HCO3
2, OH2, I2 or formate (1–4). The different
transporters of the SLC26 protein family share the
sulfate transporter domain (pfam 00 916.11; pfam
contains hidden Markov model based profiles of
many common protein domains based on multiple
sequence alignments (5)), which is most probably
involved in the anion exchange mechanism, as well
as an STAS domain (pfam 01 740.11 (5)), which
seems to be involved in the binding of nucleotides
and/or the interaction with the cAMP-dependent
chloride channel CFTR (cystic fibrosis transmembrane
conductance regulator) (6). The latter mechanism
was used to explain the rheogenic behaviour
of SLC26A3 (also known as down-regulated in
adenoma; DRA) and SLC26A6 when expressed in
Xenopus laevis oocytes (7). This issue, however
seems to be controversial, since in recent studies in
which SLC26A3 was expressed in Xenopus laevis
oocytes or human embryonic kidney (HEK 293)
cells, only an electroneutral chloride transport could
be evidenced (8 –10). In the pancreas, the bicarbon-
ate secretion at the apical membrane of the duct
cells is envisioned to be potential dependent, and
again it is unclear whether this is mediated by elec-
trogenic SLC26 transporters, or electroneutral
SLC26 transporters functionally linked to CFTR chlor-
ide channels (11). It can be concluded from these
reports that probably, as for the specificity of the
exchanging anions mentioned above, the issue of
the transporters electrogenicity also depends on the
circumstances (species and cell type) in which the
protein is expressed.
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Recently it was shown that SLC26A7 (12) expressed
in Xenopus laevis oocytes or HEK 293 cells, as well as
SLC26A4 (13) expressed in COS-7 cells, led to electro-
genic chloride permeation across the cell membrane.
We have shown that SLC26A4 can be functionally
expressed in HEK 293 Phoenix cells, leading to an
increased chloride uptake.
This increased chloride uptake can be blocked by the
chloride channel blocker (5-nitro-2-(3-phenylpropyl-
amino) benzoic acid (NPPB), and is reduced when a
mutated SLC26A4 protein isolated from a patient
with Pendred syndrome was used for the expression
studies (14).
The aim of the present work was to get further insight
into the function of pendrin expressed in human cells.
We were particularly interested in whether pendrin
expressed in HEK 293 Phoenix cells, similarly as
described for COS-7 cells (13), is able to lead to chloride
currents. Here we show that pendrin expressed in HEK
293 Phoenix cells does not lead to chloride currents.
However, the expression of SLC26A4 leads to the stimu-
lation of two kinds of cationic currents when expressed in
human cells, namely: (i) an unselective, small amplitude
cationic current, and (ii) a selective, voltage-dependent,
outwardly rectifying potassium current. The exper-
iments reported here suggest therefore, that the
SLC26A4-mediated chloride transport is electroneutral
when the expression is performed in human HEK 293
Phoenix cells.
Material and methods
Cloning of SLC26A4 cDNA
Standard procedures were used for DNA preparation,
cloning, purification and sequencing. The human
wild-type SLC26A4 cDNA was obtained by RT-PCR,
using total RNA from normal human thyroid tissue
and Taq PLATINUM Pfx DNA polymerase (Invitro-
gen). The SLC26A4 open reading frame was cloned
into pIRES2-EGFP (Clontech). This vector permits
both the cDNA of interest (cloned into the multiple
cloning site (MCS)) and the enhanced green fluor-
escence protein (EGFP) coding sequence to be trans-
lated from a single bicistronic mRNA, and therefore
to produce two separated proteins simultaneously.
The EGFP fluorescence (excitation maximum
¼ 488 nm; emission maximum ¼ 509 nm) enables
us to identify the cells expressing the protein of inter-
est, and therefore to optimize the transfection pro-
cedure and to control the transfection efficiency.
The whole-cell current measurements were restricted
to the cells showing an EGFP fluorescence.
Cell culture and transient transfection
HEK 293 Phoenix cells were grown in minimum essen-
tial Eagle medium (Sigma) supplemented with 10%
foetal bovine serum (Cambrex Bio Science), 2 mM
L-glutamine, 100 units/ml penicillin, 100mg/ml strep-
tomycin and 1 mM pyruvic acid (sodium salt). The cells
were maintained at 37 8C in a 5% CO2:95% air humidi-
fied incubator; subcultures were routinely established
every second to third day by seeding the cells into
Petri dishes (diameter 100 mm) after trypsin/EDTA
treatment. For patch-clamp, HEK cells were transfected
with the pIRES2-EGFP vector coding for wild-type
SLC26A4, or with the empty plasmid (negative con-
trols) expressing only the EGFP protein and then
seeded on glass coverslips (diameter 10 mm).
Whole-cell patch-clamp
Transfected cells were selected by visualizing EGFP-
expressing cells with an inverted fluorescence micro-
scope (Axiovert 135, Zeiss). Single transfected cells
were voltage-clamped using the patch-clamp technique
previously described (15, 16). The resistance of the
glass pipettes was 3-8 MVwhen filled with the respective
solutions (Tables 1 and 2) ; fast exchange of the bath sol-
ution was obtained using a perfusion system with a flow
rate of 5 ml/min and a bath volume of ,300ml. When
chloride in the bath solution was changed, the reference
electrode was connected via an agar bridge containing
100 mM KCl. All experiments were carried out at room
temperature. For data acquisition, an EPC-9 (HEKA Elek-
tronik, Germany) amplifier was used, controlled by a
Macintosh computer running the Pulse (HEKA) pro-
gram. Access resistance, and fast and slow capacitance
were compensated and monitored throughout the
recordings. All current measurements were filtered at
2.9 kHz and digitized at 2 kHz. For data analysis, the
Pulse-Fit (HEKA) and Excel (Microsoft) programs were
used. The cells were held at 260 mV and step pulses
were applied of 500 ms duration from 2120 to
100 mV in 20 mV steps. Tail Kþ currents were recorded
after a 30-ms depolarizing pre-pulse to þ60 mV from a
holding potential of 260 mV. Membrane potentials
were corrected for liquid junction potentials. Where indi-
cated, membrane currents were leak-subtracted, and the
compositions of the solutions are given in Tables 1 and 2.
Table 1 Composition (in mM) of the different pipette solutions






MgCl2 5 5 5
EGTA 10 10 5
Mg2þ ATP 2 2 5
HEPES 10 10 5
Raffinose 20 20
pH 7.2 7.2 7.2
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Drugs and chemicals
All drugs and chemicals used are of pro analysis grade.
Statistical analyses
Data are expressed as arithmetic means^S.E. Statistical
analysis was made by the unpaired or, where appli-
cable, paired t-test. Statistically significant differences
were assumed at P , 0.05.
Results
Functional expression of SLC26A4 in HEK 293
Phoenix cells
Recently we showed that pendrin (SLC26A4), when
expressed in HEK 293 Phoenix cells, leads to an
increased chloride uptake, which was blocked by the
addition of NPPB (14). NPPB is known to block chlor-
ide transport (17), and since in a earlier study it was
shown that SLC26A4 leads to chloride currents when
expressed in COS-7 cells (13), we set out to investigate
whether SLC26A4 expressed in human HEK 293 Phoe-
nix cells is able to lead to rheogenic chloride transport
effected by selective chloride channels.
In order to monitor the SLC26A4 expression in HEK
293 Phoenix cells, we used an IRES-vector allowing
the simultaneous expression of SLC26A4 and the
marker protein EGFP, which can be verified by fluor-
escence. As shown in Fig. 1a, the expression of
SLC26A4 in HEK 293 Phoenix cells is able to elicit
small but statistically significant currents in the inward
direction (range of the holding potentials is between
224 and 2124 mV) and in the outward direction at
þ76 mV. At these potentials the SLC26A4-induced cur-
rents are significantly higher if compared with control
currents measured after the expression of the EGFP
marker protein alone. The pipette and extracellular sol-
utions used were composed to measure selective chloride
currents (the solutions used are for technical reasons not
able to exclude unselective cation currents, however they
exclude selective potassium currents (see Tables 1 and 2,
Table 2 Composition (in mM) of the different extracelluar (bath)
solutions used as indicated in the text.
Bath
1 2 3 4 5 6 7
NaCl 125 140 5.4 130




MgCl2 2.5 2.5 2.5 0.5 0.5 0.5 0.5
CaCl2 2.5 2.5 2.5 1.8 1.8 1.8 1.8
HEPES 10 10 10 5 5 5 5
Mannitol 50 50 50
Glucose 5 5 5 5
pH 7.4 7.4 7.4 7.4 7.4 7.4 7.4
Figure 1 Expression of SLC26A4 in HEK 293 Phoenix cells does
not induce chloride currents, but barium-sensitive cationic cur-
rents. (a) The currents were measured with and without SLC26A4
expression in the presence of high extracellular and intracellular
chloride and in the absence of potassium (bath solution 1 and pip-
ette solution 1; Tables 1 and 2). (b) The SLC26A4-induced cur-
rents are not sensitive to NPPB, a substance known to block
chloride channels. (c) The SLC26A4-induced currents can be
blocked by 1 mM barium.
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pipette solution 1 and bath solution 1 (16, 18–20)).
Since the reversal potential of the SLC26A4-induced
currents is slightly negative (211.4^2.7 mV, n ¼ 69,
and not significantly different from the control reversal
potential at 218.4^3.1 mV, n ¼ 74), the measured
inward current is most probably the result of an
unselective cationic current carried by sodium. That
chloride is responsible for the observed inward currents
seems not to be very likely, since the calculated reversal
potential for chloride (symmetrical chloride concen-
trations) should be 0 mV, and the use of 0.1mM NPPB,
a substance used to block a wide range of chloride chan-
nels (17), does not reduce the observed inward currents
(Fig. 1b). The SLC26A4-induced currents seem therefore
to be the result of an unselective cation current. Accord-
ingly, as shown in Fig. 1c, the SLC26A4-enhanced
inward current can be blocked by 1 mM barium, and sub-
stituting the intracellular (pipette) caesium for N-
methly-D-glucamine (NMDG) (pipette solution 2, bath
solution 1; Fig. 2a) abolishes the pendrin-induced
currents, as does the substitution of the extracellular
cation (sodium) for NMDG (bath solution 2, pipette
solution 1; Fig. 2b). Therefore, the SLC26A4-induced
currents require diffusible cations, which need to be sim-
ultaneously present on either side of the channel pores.
In order to test whether the cation (sodium)-carried
SLC26A4-induced inward currents can be modified by
the presence of potassium in the extracellular fluid we
exchanged the extracellular sodium for potassium
(bath solution 3, pipette solution 1). As shown in Fig.
3, at a potential range from 2140 to þ60 mV, the pre-
sence of potassium indeed leads to a modest, but signifi-
cant, increase of the respective currents. Most important
are the findings that: (i) at holding potentials between
240 and þ10 mV the SLC26A4 currents acquire an
additional inward component if compared with the
SLC26A4 currents in the absence of potassium but in
the presence of sodium (bath solution 1, pipette solution
1; Fig. 1); (ii) the reversal potential in the presence of pot-
assium is no longer negative but positive
(þ14.3^4.1 mV, n ¼ 10). These findings can only be
explained by the appearance of voltage-dependent pot-
assium currents, which are less selective for caesium
compared with potassium. Since the experiments carried
out so far had not revealed any chloride currents, but
clearly showed that SLC26A4 is able to stimulate pre-
sumably two different cationic currents, we decided to
repeat the experiments by using pipette solutions as
well as extracellular solutions that enable the investi-
gation of cationic currents.
Expression of SLC26A4 in HEK 293 Phoenix
cells leads to the activation of voltage-
dependent potassium currents
For all further experiments, solutions were used that
allow for the characterization of potassium currents
Figure 2 Substituting the permeant cation (caesium in the pipette
solution or sodium in the extracellular solution with the non-per-
meant NMDG abolishes the SLC26A4-induced currents. (a) Intra-
cellular (pipette) caesium is substituted by NMDG (bath solution 1
and pipette solution 2). (b) Extracellular sodium is substituted by
NMDG (bath solution 2 and pipette solution 1).
Figure 3 Substituting extracellular sodium with potassium
unmasks a voltage-dependent potassium current, activated at
220 mV in cells expressing SLC26A4 (bath solution 3 and pipette
solution 1).
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(Tables 1 and 2) (13). However, these solutions do not
allow for discrimination between chloride or potassium
currents; this is only a minor problem since the
expression of SLC26A4 in human HEK cells does not
activate, as reported above, chloride currents.
The omission of caesium (a known blocker for selective
potassium channels (21)) and the addition of potassium
to the pipette solutions as well as the extracellular sol-
utions leads already under control conditions to vol-
tage-dependent outwardly rectifying currents (bath
solution 4, pipette solution 3; Fig. 4). The outwardly rec-
tifying currents were significantly enhanced after the
expression of SLC26A4 (Fig. 4). As shown in Fig. 4a,
the kinetics of the elicited currents resemble outwardly
rectifying and voltage-dependent potassium currents of
the Kv channel family (22). The currents showed rapid
activation and little inactivation at holding potentials
above þ40 mV, within the 500 ms tested. The current
onset was best fit by a raising exponential of the form
I ¼ Ipeak 1 2 eð2t=tÞ
h i
where Ipeak is the peak current and t is the time constant
of the exponential. The time constants ranged from
51.3^11.5 ms (n ¼ 21) at 215 mV to 2.3^0.3 ms
(n ¼ 21) at þ85 mV. Under control conditions, at the
same holding potentials, the time constants were
43.6^7.5 ms (n ¼ 21) at 215 mV and 2.5^0.3 ms
(n ¼ 27) at þ85 mV respectively, values which are not
statistically different from the SLC26A4-induced cur-
rents (Fig. 4c).
The voltage-dependent potassium channels can be
blocked by tetraethyl ammonium (TEA) (22). As
shown in Fig. 5a, the SLC26A4 as well as control cur-
rents can be blocked by 10 mM TEA (bath solution 7,
pipette solution 3). We consider the remaining currents
in the presence of TEA as ‘lumped leak currents’, and
subtracted them from the currents in the presence of
SLC26A4 (Fig. 5b). This leads to an I–V plot typical
for voltage-dependent outward-rectifying potassium
currents, with an activation potential around 220 mV.
Tail currents (Fig. 6a) revealed the potassium selec-
tivity of the SLC26A4-induced currents. As shown
in Fig. 6b, the presence of 5.4 mM potassium in
Figure 4 Expression of SLC26A4 in HEK 293 Phoenix cells stimu-
lates voltage-dependent outward-rectifying potassium currents.
(a) Two leak-subtracted original tracings (left, under control con-
ditions; right, after the expression of SLC26A4). (b) Summary of
the experiments shown in panel a. (c) t values of activation for
holding potentials ranging from 220 to þ100 mV. For these
experiments bath solution 4 and pipette solution 3 were used.
Figure 5 The SLC26A4-stimulated potassium current can be
blocked by TEA. (a) Addition of 10 mM TEA leads to inhibition of
the pendrin-induced current, as well as the current under control
conditions (bath solution 7 and pipette solution 3). The remaining
current in the presence of 10 mM TEA was subtracted from the
control, as well as the SLC26A4-induced current and the result is
given in panel b.
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the extracellular bath fluid, and 140 mM potassium in
the pipette solution leads to a reversal potential of
280.1^4.9 mV (n ¼ 12); a value close to the calcu-
lated 279.8 mV obtained after transforming the con-
centrations into the respective activities (bath solution
4, pipette solution 3) (23). Increasing the extracellular
potassium concentration to 140 mM leads to a shift to
20.2^0.7 mV (n ¼ 11), a value not significantly differ-
ent from the expected 0 mV (bath solution 5, pipette
solution 3). However, in contrast, changing the extra-
cellular chloride concentration does not significantly
change the measured reversal potential (from
264.8^9.8 mV (n ¼ 8) to 275.9^3.2 mV (n ¼ 8);
bath solution 6 and pipette solution 3), again indicat-
ing that the SLC26A4-induced current is potassium
selective, and not a chloride current. The lack of any
chloride currents in the presence of SLC26A4 is,
however, in contrast to the findings reported by
Yoshida et al. (13), who used exactly the same solutions
that we used to characterize the potassium currents.
Discussion
The SLC26A4 protein is mainly expressed in the thyroid
gland, inner ear and the kidney, and its malfunction leads
to Pendred syndrome (PS; OMIM 274600), a disease
often characterized by prelingual deafness and/or
goiter (24, 25). The detailed function of the SLC26A4
protein is still elusive. In the inner ear SLC26A4 seems
to be involved in the conditioning of the endolymphatic
fluid (26, 27), and in the kidney it is involved in bicarbon-
ate secretion (28 –30). In both cases, it is most probable
that SLC26A4 is acting as a Cl2/HCO3
2 exchanger. In the
thyroid gland, however, SLC26A4 is supposed to trans-
port iodide (31). A crucial question for the function of
SLC26A4 in the different organ systems, and therefore
interpretation of its action in different modular systems
(32), is whether or not the transporter itself is electro-
genic. Our experiments, in which we expressed the
human pendrin in a human cell line, show that the
SLC26A4 ion transporter is not, per se, electrogenic;
however, the expression of the transporter leads to an
increased chloride uptake in these cells (14), which
therefore needs to be electroneutral. Our data demon-
strate that the expression of SLC26A4 in HEK 293 Phoe-
nix cells leads to the activation of pre-existing unselective
cation currents as well as voltage-dependent outwardly
rectifying potassium currents. The activation of these
currents seems not to be the result of an unspecific per-
turbation of endoplasmic reticulum function – triggered
by the heterologous protein expression (33) – since the
activation of the above-mentioned currents by
SLC26A4 was compared with control cells, which
already express a heterologous protein (i.e. EGFP).
Furthermore, our findings indicate that in the
absence of SLC26A4, a reduced activity of outwardly
rectifying potassium channels can be measured,
which could aggravate the situation described by Wan-
gemann et al. (34) (i.e. the loss of the endocochlear
potential in SLC26A42/2 mice due to the loss of
KCNJ10 potassium channels), and therefore further
explains the hearing loss evidenced in those animals.
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